Skip to main content

Peer Review reports

From: Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study

Original Submission
29 Nov 2016 Submitted Original manuscript
16 Feb 2017 Reviewed Reviewer Report - Yanhong Liu
16 Jul 2017 Reviewed Reviewer Report - Luigi De Petris
15 Sep 2017 Author responded Author comments - Wolfgang Schütte
Resubmission - Version 2
15 Sep 2017 Submitted Manuscript version 2
8 Oct 2017 Reviewed Reviewer Report - Luigi De Petris
7 Dec 2017 Author responded Author comments - Wolfgang Schütte
Resubmission - Version 3
7 Dec 2017 Submitted Manuscript version 3
Publishing
23 Jan 2018 Editorially accepted
5 Feb 2018 Article published 10.1186/s12885-018-4032-3

You can find further information about peer review here.

Back to article page